Functional MRI And MR Spectroscopic Studies Of Penicillin Induced And Kindled Sheep Models Of Epilepsy
Funder
National Health and Medical Research Council
Funding Amount
$311,244.00
Summary
Epilepsy is one of the most common neurological disorders, affecting 1-2% of the population. Many epilepsy patients do not respond to drug therapy and their only hope for seizure control is surgical removal of the part of the brain responsible for their seizures. Successful surgery is very much dependent on the ability to exactly localize the seizure focus and this is often not possible using the imaging techniques currently available. Functional magnetic resonance imaging (fMRI) is a new techni ....Epilepsy is one of the most common neurological disorders, affecting 1-2% of the population. Many epilepsy patients do not respond to drug therapy and their only hope for seizure control is surgical removal of the part of the brain responsible for their seizures. Successful surgery is very much dependent on the ability to exactly localize the seizure focus and this is often not possible using the imaging techniques currently available. Functional magnetic resonance imaging (fMRI) is a new technique which may improve our ability to localize the seizure focus from which seizures arise, if the brain can be imaged at, or near, the time of a seizure. MR spectroscopy (MRS) enables us to detect metabolic changes in the brain which may persist at the site where seizures have begun for up to 30 minutes after the seizure. The aim of our research is to obtain a greater understanding of the changes detected with these MR modalities so that we can learn to apply these techniques to human sufferers of epilepsy. Ultimately it may help enable previously incurable epilepsy patients to undergo successful surgery and live normal lives.Read moreRead less
I am a cardiovascular physiologist investigating the origin of the large increases in cardiac and renal sympathetic nerve activity in heart failure,the causes of acute renal failure in septic shock and mechanisms to reduce myocardial ischaemia-reperfusion
The Victorian Centre For Applied Biostatistics (VCAB): Building Core Methodological Capacity For Population Health
Funder
National Health and Medical Research Council
Funding Amount
$2,497,184.00
Summary
Biostatistics is the scientific discipline that focusses on the methods used to design and analyse research studies on human health. Doctors and other researchers conduct increasingly complex studies to identify best approaches for the prevention and treatment of disease, and these studies must be underpinned by sound biostatistical methods. This Centre will develop a critical mass of expertise in this under-resourced area around a program of methodological research, translation and training.
The Centre for Research Excellence in Discovering Indigenous Strategies to improve Cancer Outcomes Via Engagement, Research Translation and Training (DISCOVER-TT) aims to reduce the marked disparities in diagnosis, treatment and survival for Indigenous Australians with cancer. DISCOVER-TT’s co-ordinated, collaborative, Indigenous-led research program will feature extensive stakeholder engagement to ensure its work is relevant and applicable, and will enhance research capacity by developing early ....The Centre for Research Excellence in Discovering Indigenous Strategies to improve Cancer Outcomes Via Engagement, Research Translation and Training (DISCOVER-TT) aims to reduce the marked disparities in diagnosis, treatment and survival for Indigenous Australians with cancer. DISCOVER-TT’s co-ordinated, collaborative, Indigenous-led research program will feature extensive stakeholder engagement to ensure its work is relevant and applicable, and will enhance research capacity by developing early-career researchers.Read moreRead less
Many cancers shed small amounts of DNA (circulating tumour DNA or ctDNA) into the patient’s bloodstream. Recent technological advances now allow levels of ctDNA to be accurately measured in the blood. Changes in ctDNA levels have potential to be used as specific markers of disease progression and/or response to cancer therapy. This research will advance the use of ctDNA to serially follow patients and individualise treatment decisions in cancer management across several cancer types.